1-155950867-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001162383.2(ARHGEF2):c.2665G>T(p.Ala889Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000788 in 1,395,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001162383.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000512 AC: 1AN: 195126Hom.: 0 AF XY: 0.00000953 AC XY: 1AN XY: 104944
GnomAD4 exome AF: 0.00000788 AC: 11AN: 1395634Hom.: 0 Cov.: 32 AF XY: 0.00000727 AC XY: 5AN XY: 687408
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2665G>T (p.A889S) alteration is located in exon 20 (coding exon 20) of the ARHGEF2 gene. This alteration results from a G to T substitution at nucleotide position 2665, causing the alanine (A) at amino acid position 889 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at